AJR InPractice
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barth, R. J.
Right arrow Articles by Poplack, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barth, R. J., Jr.
Right arrow Articles by Poplack, S. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2005; 184:324-329
© American Roentgen Ray Society

Detection of Breast Cancer on Screening Mammography Allows Patients to Be Treated with Less-Toxic Therapy

Richard J. Barth, Jr.1, Glen R. Gibson1, Patricia A. Carney2, Leila A. Mott2, Robert D. Becher1 and Steven P. Poplack3

1 Department of Surgery, Section of General Surgery, Dartmouth-Hitchcock Medical Center, Dartmouth Medical School and the Norris Cotton Cancer Center, Lebanon, NH 03756.
2 Department of Community and Family Medicine, Dartmouth-Hitchcock Medical Center, Dartmouth Medical School and the Norris Cotton Cancer Center, Lebanon, NH.
3 Department of Radiology, Dartmouth-Hitchcock Medical Center, Dartmouth Medical School and the Norris Cotton Cancer Center, Lebanon, NH 03756.

OBJECTIVE. Therapy for breast cancer is accompanied by acute and chronic toxicity. Little research has been conducted to determine the impact of the mode of breast cancer detection on the likelihood of receiving different types of treatment. The objective of this study was to determine whether detection of breast cancer on screening mammography is associated with less-toxic therapy.

MATERIALS AND METHODS. The study group for this retrospective cohort study consisted of 992 women with invasive breast cancer detected on screening mammography (n = 460) or at physical examination (n = 532) at a single institution between 1990 and 2001. To address the generalizability of study findings, we compared the characteristics of study participants with those diagnosed with breast cancer in a population-based mammography registry.

RESULTS. The patients whose breast cancer was detected on screening mammography more frequently had lymph nodes free of metastases (84% vs 58%, p < 0.0001), had smaller tumors (1.5 vs 2.9 cm, p < 0.0001), were more likely to be treated with breast conservation (56% vs 32%, p < 0.0001), and were less likely to be treated with chemotherapy (28% vs 56%, p < 0.0001). In a multivariate analysis with adjustments for age and functional status, patients whose cancer was detected at physical examination were more than twice as likely to undergo mastectomy (odds ratio [OR], 2.5; 95% confidence interval [CI], 1.9–3.3) and nearly three times as likely to be treated with chemotherapy (OR, 2.9; 95% CI, 2.1–3.9). For younger women (40–49 years old), the likelihood of receiving chemotherapy was more than doubled if the cancer was detected at physical examination rather than on screening mammograms (OR, 2.3; 95% CI, 1.3–4.0). For older women (≥ 70 years old), patients whose cancer was detected at physical examination were five times more likely to undergo mastectomy (OR, 5.8; 95% CI, 3.2–10.5) and four times more likely to receive chemotherapy (OR, 4.6; 95% CI, 1.6–13) than the group whose tumors were detected on screening mammography.

CONCLUSION. Breast cancers detected on screening mammography are smaller, are less likely to metastasize to lymph nodes, and are more likely to be treated with breast conservation and without chemotherapy. These findings provide an additional rationale for performing screening mammography, especially for women at age extremes for whom the survival benefit of screening mammography is debated.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
K. Armstrong, E. Moye, S. Williams, J. A. Berlin, and E. E. Reynolds
Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians
Ann Intern Med, April 3, 2007; 146(7): 516 - 526.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
M. McCulloch, T. Jezierski, M. Broffman, A. Hubbard, K. Turner, and T. Janecki
Diagnostic Accuracy of Canine Scent Detection in Early- and Late-Stage Lung and Breast Cancers
Integr Cancer Ther, March 1, 2006; 5(1): 30 - 39.
[Abstract] [PDF]


Home page
Am. J. Roentgenol.Home page
J. W. T. Leung
Screening Mammography Reduces Morbidity of Breast Cancer Treatment
Am. J. Roentgenol., May 1, 2005; 184(5): 1508 - 1509.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Roentgen Ray Society.